Ticker Hub
SLNO — AI Analysis & Sentiment
7 recent AI-generated analyses for SLNO. Sentiment and confidence insights updated continuously.
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
A new class action lawsuit alleges Soleno Therapeutics misrepresented safety data for its lead drug, posing significant risks to its commercial fut...
Apr 21, 2026Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
The DJS Law Group's announcement of a class action lawsuit against Soleno Therapeutics for securities law violations further compounds legal risks ...
Mar 23, 2026SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical Trials - Soleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt
Soleno Therapeutics faces a significant challenge as a lawsuit alleges sham clinical trials for its lead drug, DCCR, its primary revenue driver. Th...
Mar 12, 2026Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
Soleno Therapeutics faces increased legal pressure from a securities fraud class action, directly impacting the commercial viability of its sole dr...
Mar 12, 2026SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The company faces significant legal uncertainty regarding its key drug, which could materially impact its value. This makes the stock a potential s...
Mar 12, 2026SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
A class action lawsuit alleging safety concerns for Soleno's lead drug, DCCR, creates significant bear-case risk. The market has yet to react to th...
Mar 9, 2026Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
Soleno Therapeutics has achieved a significant milestone by reporting its first profitable year and strong revenue from VYKAT XR's U.S. launch. Thi...
Feb 25, 2026